A new blood test called p-tau217 shows promise as an Alzheimer’s disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest pathology.
Click here for original story, New blood test gives very high accuracy to screen for Alzheimer’s disease
Source: ScienceDaily